Her Majesty's Government what plans they have to introduce a "transformative designation", as proposed in the Accelerated Access Review, for the most strategically important products for the NHS.
11 July 2017
In October 2016 the Accelerated Access Review set out a vision of faster patient access to 21st century medicines and medical technologies, making the United Kingdom a world leading place to design, develop and deploy medical innovations.
The review made several recommendations to ensure that patients get new drugs and treatments faster while the National Health Service gets best value for money and remains at the forefront of innovation. The Government and its key delivery partners are reviewing the review’s recommendations and will respond in due course.